Besides, based on the ARCHS4 database (Lachmann et al., 2018), IL-32 was predicted to be involved in hepatitis B, cytokine–cytokine receptor interaction, and viral carcinogenesis pathways (Figure 2B). The gene discussed is IL32; the disease is hepatitis B virus infection.